Trial intelligence / Profile preview

PerioRegen: Autologous BM-MSCs for Periodontal Defects

NCT02449005Phase 2Completed

Sponsor
Aristotle University of Thessaloniki
Start
Mar 2014
Primary completion
Sep 2016
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of autologous alveolar bone marrow mesenchymal stem cells in chronic periodontitis, sponsored by Aristotle University of Thessaloniki. Started Mar 2014; status: completed.

02

Drugs

autologous alveolar bone marrow mesenchymal stem cells
03

Conditions

chronic periodontitis

Beyond the preview

Go deeper on NCT02449005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02449005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call